These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Neragi-Miandoab S; Richards WG; Sugarbaker DJ Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112 [TBL] [Abstract][Full Text] [Related]
4. Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis. Ghanim B; Hoda MA; Winter MP; Klikovits T; Alimohammadi A; Hegedus B; Dome B; Grusch M; Arns M; Schenk P; Pohl W; Zielinski C; Filipits M; Klepetko W; Berger W Ann Surg; 2012 Aug; 256(2):357-62. PubMed ID: 22750759 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis. Al-Alao BS; Parissis H; Rychlik IJ; Graham A; McGuigan J Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):443-9. PubMed ID: 22879552 [TBL] [Abstract][Full Text] [Related]
6. Can serum inflammatory parameters estimate outcome of pleurodesis in mesothelioma? Bilgin M; Hasdiraz L; Ozkaya M; Oguzkaya F ANZ J Surg; 2007 Apr; 77(4):253-5. PubMed ID: 17388830 [TBL] [Abstract][Full Text] [Related]
7. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile? Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152 [TBL] [Abstract][Full Text] [Related]
9. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622 [TBL] [Abstract][Full Text] [Related]
10. Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. Yan TD; Boyer M; Tin MM; Sim J; Kennedy C; McLean J; Bannon PG; McCaughan BC Ann Thorac Surg; 2009 May; 87(5):1552-6. PubMed ID: 19379903 [TBL] [Abstract][Full Text] [Related]
11. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625 [TBL] [Abstract][Full Text] [Related]
13. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481 [TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan. Nojiri S; Gemba K; Aoe K; Kato K; Yamaguchi T; Sato T; Kubota K; Kishimoto T Jpn J Clin Oncol; 2011 Jan; 41(1):32-9. PubMed ID: 20798232 [TBL] [Abstract][Full Text] [Related]
15. Malignant pleural mesothelioma: surgical management in 285 patients. Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for 100 patients with malignant pleural mesothelioma. Gonlugur U; Gonlugur TE Arch Environ Occup Health; 2010; 65(2):65-9. PubMed ID: 20439224 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis. Leuzzi G; Rea F; Spaggiari L; Marulli G; Sperduti I; Alessandrini G; Casiraghi M; Bovolato P; Pariscenti G; Alloisio M; Infante M; Pagan V; Fontana P; Oliaro A; Ruffini E; Ratto GB; Leoncini G; Sacco R; Mucilli F; Facciolo F Ann Thorac Surg; 2015 Sep; 100(3):890-7. PubMed ID: 26163973 [TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma: a population-based study of survival. Milano MT; Zhang H J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379 [TBL] [Abstract][Full Text] [Related]
19. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742 [TBL] [Abstract][Full Text] [Related]
20. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma. Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]